INS and type 2 diabetes mellitus: The most commonly studied populations were non-insulin-treated patients (18, 32, 46, 55), those with moderately controlled diabetes (HbA1c > 7%) (34, 46, 47, 49, 55), newly diagnosed patients (< 1 year) (39, 55), and adults with T2DM.